Inventor · disambiguated record
Jeffrey V. Ravetch
Also filed as: RAVETCH JEFFREY · RAVETCH JEFFREY V
33 granted patents·40 pending applications·506 citations·filing 1986–2025
97Inventor score
Files withUNIV ROCKEFELLER52RAVETCH JEFFREY V12SLOAN KETTERING INST CANCER4UNIV CALIFORNIA2DHODAPKAR MADHAV V1
Top patents by PatentIndex Score
73 records- 0197US7416726B2Enhancement of antibody-mediated immune responsesUNIV ROCKEFELLER·Filed 2001·Granted Aug 26, 2008·120 cites·41 claims
- 0296US6676927B1Animal model and methods for its use in the selection of cytotoxic antibodiesUNIV ROCKEFELLER·Filed 2000·Granted Jan 13, 2004·91 cites·16 claims
- 0395US5877396AMice mutant for functional Fc receptors and method of treating autoimmune diseasesSLOAN KETTERING INST CANCER·Filed 1994·Granted Mar 2, 1999·145 cites·18 claims
- 0490US8815237B2Aglycosylated immunoglobulin mutantsWITTRUP K DANE·Filed 2008·Granted Aug 26, 2014·16 cites·19 claims
- 0589US8470318B2Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methodsRAVETCH JEFFREY V·Filed 2007·Granted Jun 25, 2013·28 cites·7 claims
- 0687US10479838B2Antibodies to CD40 with enhanced agonist activityUNIV ROCKEFELLER·Filed 2016·Granted Nov 19, 2019·7 cites·10 claims
- 0786US9481724B2hDC-sign binding peptidesUNIV ROCKEFELLER·Filed 2012·Granted Nov 1, 2016·7 cites·21 claims
- 0885US7846744B2Methods of identifying anti-inflammatory compoundsRAVETCH JEFFREY V·Filed 2009·Granted Dec 7, 2010·8 cites·15 claims
- 0984US10894835B2Antibodies to CD40 with enhanced agonist activityUNIV ROCKEFELLER·Filed 2016·Granted Jan 19, 2021·5 cites·10 claims
- 1083US12186385B2Immune complexUNIV ROCKEFELLER·Filed 2023·Granted Jan 7, 2025·0 cites·16 claims
- 1183US2023121427A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2022·Application pending·0 cites
- 1282US8618251B1Fc mutantsRAVETCH JEFFREY V·Filed 2010·Granted Dec 31, 2013·4 cites·11 claims
- 1382US8470321B2Antibodies specific for the protofibril form of beta-amyloid proteinRAVETCH JEFFREY V·Filed 2008·Granted Jun 25, 2013·8 cites·18 claims
- 1481US10167332B2Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methodsRAVETCH JEFFREY V·Filed 2007·Granted Jan 1, 2019·5 cites·4 claims
- 1580US10882917B2Anti-tumor agents and methods of useUNIV ROCKEFELLER·Filed 2016·Granted Jan 5, 2021·2 cites·8 claims
- 1678US12384848B2Anti-inflammatory polypeptidesUNIV ROCKEFELLER·Filed 2023·Granted Aug 12, 2025·0 cites·10 claims
- 1778US9657101B2FC mutantsUNIV ROCKEFELLER·Filed 2013·Granted May 23, 2017·1 cites·10 claims
- 1875US11613579B2Anti-inflammatory polypeptidesUNIV ROCKEFELLER·Filed 2020·Granted Mar 28, 2023·0 cites·17 claims
- 1974US11608379B2Anti-inflammatory polypeptidesUNIV ROCKEFELLER·Filed 2020·Granted Mar 21, 2023·0 cites·12 claims
- 2074US2021101961A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2020·Application pending·0 cites
- 2173US2020385443A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2019·Application pending·0 cites
- 2272US11690905B2Immune complexUNIV ROCKEFELLER·Filed 2021·Granted Jul 4, 2023·0 cites·21 claims
- 2372US2023057150A1HUMAN IgG Fc DOMAIN VARIANTS WITH IMPROVED EFFECTOR FUNCTIONUNIV ROCKEFELLER·Filed 2022·Application pending·0 cites
- 2471US10844125B2Anti-inflammatory polypeptidesUNIV ROCKEFELLER·Filed 2016·Granted Nov 24, 2020·1 cites·16 claims
- 2571US2025171558A1HUMAN IgG Fc DOMAIN VARIANTS WITH IMPROVED EFFECTOR FUNCTIONUNIV ROCKEFELLER·Filed 2025·Application pending·0 cites
- 2670US2025154253A1TARGETING CD47 WITH Fc-ENHANCED ACTIVITYUNIV ROCKEFELLER·Filed 2024·Application pending·0 cites
- 2769US11760805B2Antibodies to CD40 with enhanced agonist activityUNIV ROCKEFELLER·Filed 2021·Granted Sep 19, 2023·0 cites·4 claims
- 2868US10973904B2Immune complexUNIV ROCKEFELLER·Filed 2019·Granted Apr 13, 2021·0 cites·20 claims
- 2968US2019127446A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2019·Application pending·0 cites
- 3068US2019031738A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2018·Application pending·0 cites
- 3167US10894832B2Anti-inflammatory polypeptidesUNIV ROCKEFELLER·Filed 2017·Granted Jan 19, 2021·0 cites·5 claims
- 3267US2025188193A1Glycoform specific nanobodies and methods of useUNIV ROCKEFELLER·Filed 2022·Application pending·0 cites
- 3367US2019031737A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2018·Application pending·0 cites
- 3465US2024150494A1Glycoform specific nanobodies and methods of useUNIV ROCKEFELLER·Filed 2022·Application pending·0 cites
- 3564US2017320935A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2017·Application pending·0 cites
- 3664US2017283492A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2017·Application pending·0 cites
- 3764US2024279314A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2024·Application pending·0 cites
- 3864US2017218050A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2017·Application pending·0 cites
- 3964US2014323696A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2014·Application pending·0 cites
- 4063US2009060911A1Enhancement of antibody-mediated immune responsesUNIV ROCKEFELLER·Filed 2008·Application pending·0 cites
- 4163US2022162290A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2021·Application pending·0 cites
- 4262US9587025B2Non-sialylated anti-inflammatory polypeptidesUNIV ROCKEFELLER·Filed 2012·Granted Mar 7, 2017·0 cites·7 claims
- 4362US2013273040A1Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methodsUNIV ROCKEFELLER·Filed 2013·Application pending·0 cites
- 4461US2024400706A1Combination of anti-cd40 antibody and il-15 for treating cancerUNIV ROCKEFELLER·Filed 2022·Application pending·0 cites
- 4561US2017088608A1Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating MethodsUNIV ROCKEFELLER·Filed 2016·Application pending·0 cites
- 4660US9845358B2Anti-inflammatory polypeptidesRAVETCH JEFFREY V·Filed 2015·Granted Dec 19, 2017·0 cites·14 claims
- 4759US2019106496A1Methods Of Identifying Anti-Inflammatory CompoundsUNIV ROCKEFELLER·Filed 2018·Application pending·0 cites
- 4859US2018125887A1Anti-inflammatory agentsUNIV ROCKEFELLER·Filed 2017·Application pending·0 cites
- 4958US10300127B2Immune complexUNIV ROCKEFELLER·Filed 2016·Granted May 28, 2019·0 cites·19 claims
- 5058US2019300621A1HUMAN IgG Fc DOMAIN VARIANTS WITH IMPROVED EFFECTOR FUNCTIONUNIV ROCKEFELLER·Filed 2019·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →